Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer Justin A. Drake, MD, David C. Portnoy, MD, Kurt.

Slides:

Advertisements

Similar presentations

Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J

Advertisements

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

What Predicts Long-Term Survival After Heart Transplantation

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

The STS National Database

A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer Jeffrey L. Port, MD, Bhupesh Parashar,

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Benny Weksler, MD, Jennifer L. Sullivan, MD

Bryan L. Walker, BS, Christina Williamson, MD, Shawn M

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival Elizabeth A. David, MD, Robert J. Canter,

Video-Assisted Thoracoscopic Lobectomy for Lung Cancer: Current Practice Patterns and Predictors of Adoption Justin D. Blasberg, MD, Christopher W. Seder,

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD,

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J

Diaphragmatic Defect Complicating Peritoneal Dialysis

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Amr Mohammad Allama, MD The Annals of Thoracic Surgery

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer Paul J. Speicher, MD, Zachary W. Fitch,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Mohamed K. Kamel, MD, Mohamed Rahouma, MD, Benjamin Lee, MD, Sebron W

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M

Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival Daniel L. Miller, MD, William R. Mayfield, MD,

Katy A. Marino, MD, Jennifer L. Sullivan, MD, Benny Weksler, MD

John Alfred Carr, MD, Joseph J. Amato, MD, Robert S.D. Higgins, MD

Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer Usman Ahmad, MD, Traves D. Crabtree,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Who Do You Say You Are? The Annals of Thoracic Surgery

Kevin L. Anderson, MHSc, Michael S. Mulvihill, MD, Paul J

Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma Shinsuke Sasada, MD, PhD, Yoshihiro Miyata, MD, PhD,

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

The “Double-Valve” Sign in Acute Type A Aortic Dissection

Use of Amiodarone After Major Lung Resection

Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma

Abel Gómez-Caro, MD, Pedro Arguis, MD The Annals of Thoracic Surgery

Anomalous Origin of Left Pulmonary Artery From Left Subclavian Artery

Jaimin R. Trivedi, MD, MPH, Allen Cheng, MD, Michele Gallo, MD, Erin M

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma? Samuel Kim, MD, David A. Bull, MD, Linda Garland, MD,

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Pulmonary Resection for Lung Cancer in Octogenarians

Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty

Editorial Board, January 2010

Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J

Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection Emilie Perrot, MD, Benoit Guibert, MD, Pierre Mulsant,

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

A. Thomas Pezzella, MD, Sari D

The Unifocal Bilateral Bidirectional Cavopulmonary Anastomosis

Single Versus Double Lung Retransplantation Does Not Affect Survival Based on Previous Transplant Type Erin M. Schumer, MD, MPH, Jonathan D. Rice, MD,

Specialty Training and Mortality After Esophageal Cancer Resection

Stephen R. Broderick, MD, MPHS, Aalok P. Patel, BS, BA, Traves D

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

Robert Lee Replogle, September 30, 1931–May 9, 2016

Benny Weksler, MD, Manisha Shende, MD, Katie S

Neal S Goldstein, MD The Annals of Thoracic Surgery

“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Justin P. V. Zachariah, MD, Frank A. Pigula, MD, John E

The Impact of New Technology on Cardiothoracic Surgical Practice

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Kim I. de la Cruz, MD, Faisal G

Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer Asad A. Shah, MD, Mark F. Berry, MD, Ching Tzao, MD,

Presentation transcript:

Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer Justin A. Drake, MD, David C. Portnoy, MD, Kurt Tauer, MD, Benny Weksler, MD The Annals of Thoracic Surgery Volume 106, Issue 4, Pages 959-965 (October 2018) DOI: 10.1016/j.athoracsur.2018.04.074 Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Consolidated Standards of Reporting Trials diagram. (Dx = diagnosis; Chemo = chemotherapy; Preop = preoperative.) The Annals of Thoracic Surgery 2018 106, 959-965DOI: (10.1016/j.athoracsur.2018.04.074) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Overall survival in the unmatched cohort. The Annals of Thoracic Surgery 2018 106, 959-965DOI: (10.1016/j.athoracsur.2018.04.074) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Overall survival in the propensity-matched cohort. The range bars show SD. The Annals of Thoracic Surgery 2018 106, 959-965DOI: (10.1016/j.athoracsur.2018.04.074) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions